Zobrazeno 1 - 10
of 235
pro vyhledávání: '"James, Sun"'
Autor:
Michael J. Carr, James Sun, William A. Adams, Michelle M. Dugan, Syeda M. H. Naqvi, Youngchul Kim, Jane L. Messina, Ricardo J. Gonzalez, Jonathan S. Zager, John E. Mullinax
Publikováno v:
Cancer Control, Vol 30 (2023)
Background and Objectives Primary cutaneous leiomyosarcoma (cLMS), a rare, typically intradermal tumor, has previously been reported to exhibit an indolent course of disease with zero-to-low risk of local recurrence or distant metastasis. This study
Externí odkaz:
https://doaj.org/article/93775b12258842a69b36239e6c205c1c
Autor:
James Sun, Xiaojun Zhong, Junjie Ma, Weihong Sun, Hyo S. Han, Hatem H. Soliman, Loretta S. Loftus, Ricardo L. B. Costa, Avan J. Armaghani, Aixa E. Soyano‐Muller, Brian J. Czerniecki, M. Catherine Lee, John V. Kiluk, Nazanin Khakpour, Susan J. Hoover, Christine Laronga, Hung T. Khong
Publikováno v:
Cancer Medicine, Vol 10, Iss 21, Pp 7665-7672 (2021)
Abstract Background Combination CDK4/6 inhibitor and endocrine therapy has been shown to significantly improve progression‐free survival (PFS) in patients with hormone receptor (HR)‐positive, HER2‐negative metastatic breast cancer (mBC). The ai
Externí odkaz:
https://doaj.org/article/a7be7c72b7844f4fa797e6ef99b9269b
Autor:
Yun Song, John F Thompson, Frances A Collichio, Tasha Hughes, John Vetto, Dale Han, Jonathan Zager, Zeynep Eroglu, Jennifer Downs, David E Gyorki, Nikhil I Khushalani, Alexander van Akkooi, Georgia Beasley, Lisa Kottschade, Hidde M Kroon, Ann Lee, Norma E Farrow, Giorgos Karakousis, Michael Lowe, Avinash Sharma, Kristy K Broman, Amanda Nijhuis, Tina J Hieken, Jeffrey M Farma, Meghan Hotz, Jeremiah Deneve, Martin Fleming, Edmund K Bartlett, Lesly Dossett, Russell S Berman, Emma Stahlie, Jane Yuet Ching Hui, Marc Moncrieff, Jenny Nobes, Kirsten Baecher, Matthew Perez, David W Ollila, Roger Olofsson Bagge, Jan Mattsson, Harvey Chai, Jyri Teras, James Sun, Michael J Carr, Ankita Tandon, Nalan Akgul Babacan, Younchul Kim, Mahrukh Naqvi
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 10, Iss 8 (2022)
Until recently, most patients with sentinel lymph node-positive (SLN+) melanoma underwent a completion lymph node dissection (CLND), as mandated in published trials of adjuvant systemic therapies. Following multicenter selective lymphadenectomy trial
Externí odkaz:
https://doaj.org/article/5e2609c2e5e44274aabf900f1ff2c1c7
Autor:
Avani M. Kolla BPhil, Gerardo A. Vitiello MD, Erica B. Friedman MD, James Sun MD, Aishwarya Potdar MS, Hala Daou BS, Norma E. Farrow MD, Clara R. Farley MD, John T. Vetto MD, Dale Han MD, Marvi Tariq MD, Georgia M Beasley MD, Carlo M. Contreras MD, Michael Lowe MD, Jonathan S. Zager MD, Iman Osman MD, Russell S. Berman MD, Tracey N. Liebman MD, Jennifer A. Stein MD PhD, Ann Y. Lee MD
Publikováno v:
Cancer Control, Vol 28 (2021)
Background Acral lentiginous melanoma is associated with worse survival than other subtypes of melanoma. Understanding prognostic factors for survival and recurrence can help better inform follow-up care. Objectives To analyze the clinicopathologic f
Externí odkaz:
https://doaj.org/article/57f410acb38d4768a497f22089e561a6
Autor:
Kristy K, Broman, Tasha M, Hughes, Brooke C, Bredbeck, James, Sun, Dennis, Kirichenko, Michael J, Carr, Avinash, Sharma, Edmund K, Bartlett, Amanda A G, Nijhuis, John F, Thompson, Tina J, Hieken, Lisa, Kottschade, Jennifer, Downs, David E, Gyorki, Emma, Stahlie, Alexander, van Akkooi, David W, Ollila, Kristin, O'shea, Yun, Song, Giorgos, Karakousis, Marc, Moncrieff, Jenny, Nobes, John, Vetto, Dale, Han, Meghan, Hotz, Jeffrey M, Farma, Jeremiah L, Deneve, Martin D, Fleming, Matthew, Perez, Kirsten, Baecher, Michael, Lowe, Roger Olofsson, Bagge, Jan, Mattsson, Ann Y, Lee, Russell S, Berman, Harvey, Chai, Hidde M, Kroon, Juri, Teras, Roland M, Teras, Norma E, Farrow, Georgia M, Beasley, Jane Yuet Ching, Hui, Lukas, Been, Schelto, Kruijff, Brandy, Sinco, Amod A, Sarnaik, Vernon K, Sondak, Jonathan S, Zager, Lesly A, Dossett
Publikováno v:
Annals of Surgery. 277(5):1106-1115
Objective: The aim of this study was to determine overall trends and center-level variation in utilization of completion lymph node dissection (CLND) and adjuvant systemic therapy for sentinel lymph node (SLN)-positive melanoma. Summary Background Da
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8148e9aa82b592a8d19b23b3d4d03d60
https://doi.org/10.1097/SLA.0000000000005370
https://doi.org/10.1097/SLA.0000000000005370
Autor:
Michael J. Carr MD, MS, James Sun MD, Jonathan B. Cohen MD, Jinhong Liu MD, Andrew A. Serdiuk DO, Stephen R. Stewart CCP, Navin Doobay CAA, Andrew Duclos CRNA, David A. Seal CRNA, Junsung Choi MD, Jonathan S. Zager MD
Publikováno v:
Cancer Control, Vol 27 (2020)
Patients with unresectable hepatic metastases, from uveal or ocular melanoma, are challenging to treat with an overall poor prognosis. Although over the past decade significant advances in systemic therapies have been made, metastatic disease to the
Externí odkaz:
https://doaj.org/article/6e610c94c7a84080b6b7e56f02a6f3b0
Autor:
James Sun, Brian R Gastman, Lucy McCahon, Elizabeth I Buchbinder, Igor Puzanov, Michele Nanni, James M Lewis, Richard D Carvajal, Shahnaz Singh-Kandah, Anupam M Desai, Leon Raskin, Carrie M Nielson, Rubina Ismail, Jonathan S Zager
Publikováno v:
Melanoma Management, Vol 7, Iss 2 (2020)
Aim: Talimogene laherparepvec (T-VEC) is an intralesional therapy for unresectable, metastatic melanoma. T-VEC real-world use in the context of anti-PD1-based therapy requires further characterization. Materials & methods: A retrospective review of T
Externí odkaz:
https://doaj.org/article/d6ce11f0cbfb4ddbbd3ec92d879d7beb
Autor:
Sabastian, Hajtovic, James, Sun, Jasjit S, Multani, Linda L, Herrmann, Hannah, Britton, Jose, Gautreaux, Lea, Tortolero, Gillian, Harrison, John G, Golfinos, Timothy M, Shepherd, Omar, Tanweer, Dimitris G, Placantonakis
Publikováno v:
Journal of Neurosurgery. :1-12
OBJECTIVE Maximal safe resection is the goal of surgical treatment for high-grade glioma (HGG). Deep-seated hemispheric gliomas present a surgical challenge due to safety concerns and previously were often considered inoperable. The authors hypothesi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9fbc66c0268abb2805530c0368f7f2f8
https://doi.org/10.3171/2022.9.jns22842
https://doi.org/10.3171/2022.9.jns22842
Autor:
Ashish Malik, Vijay Pereira, Pawan Budhwar, Fabian Jintae Froese, Dana Minbaeva, James Sun, Anh Tuan Nguyen, Shanzi Xue
Publikováno v:
Asian Business & Management. 21:745-779
In this paper, we respond to the calls for context-specific scholarship and research on human resource management (HRM) in Asia. We provide an overview of and key insights into HRM in five Asian countries, representing five key regions: China (East A
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f5953e2d1c671f43895638f89fdc9922
https://doi.org/10.1057/s41291-022-00208-z
https://doi.org/10.1057/s41291-022-00208-z
Autor:
Zachary R. Chalmers, Caitlin F. Connelly, David Fabrizio, Laurie Gay, Siraj M. Ali, Riley Ennis, Alexa Schrock, Brittany Campbell, Adam Shlien, Juliann Chmielecki, Franklin Huang, Yuting He, James Sun, Uri Tabori, Mark Kennedy, Daniel S. Lieber, Steven Roels, Jared White, Geoffrey A. Otto, Jeffrey S. Ross, Levi Garraway, Vincent A. Miller, Phillip J. Stephens, Garrett M. Frampton
Publikováno v:
Genome Medicine, Vol 9, Iss 1, Pp 1-14 (2017)
Abstract Background High tumor mutational burden (TMB) is an emerging biomarker of sensitivity to immune checkpoint inhibitors and has been shown to be more significantly associated with response to PD-1 and PD-L1 blockade immunotherapy than PD-1 or
Externí odkaz:
https://doaj.org/article/fb907a4b3aaf43769173e9ac0018e2eb